These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 27865894)

  • 21. PPAR-gamma agonists inhibit profibrotic phenotypes in human lung fibroblasts and bleomycin-induced pulmonary fibrosis.
    Milam JE; Keshamouni VG; Phan SH; Hu B; Gangireddy SR; Hogaboam CM; Standiford TJ; Thannickal VJ; Reddy RC
    Am J Physiol Lung Cell Mol Physiol; 2008 May; 294(5):L891-901. PubMed ID: 18162602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation.
    Burris TP; Pelton PD; Zhou L; Osborne MC; Cryan E; Demarest KT
    Mol Endocrinol; 1999 Mar; 13(3):410-7. PubMed ID: 10076998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthetic peroxisome proliferator-activated receptor gamma agonists rosiglitazone and troglitazone suppress transcription by promoter 3 of the human thromboxane A2 receptor gene in human erythroleukemia cells.
    Coyle AT; Kinsella BT
    Biochem Pharmacol; 2006 Apr; 71(9):1308-23. PubMed ID: 16499875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of ciglitazone and troglitazone on the proliferation of human stomach cancer cells.
    Cheon CW; Kim DH; Kim DH; Cho YH; Kim JH
    World J Gastroenterol; 2009 Jan; 15(3):310-20. PubMed ID: 19140230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ubiquitination of p53 is involved in troglitazone induced apoptosis in cervical cancer cells.
    Chen HM; Zhang DG; Wu JX; Pei DS; Zheng JN
    Asian Pac J Cancer Prev; 2014; 15(5):2313-8. PubMed ID: 24716976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Troglitazone, a ligand of peroxisome proliferator-activated receptor-{gamma}, stabilizes NUCB2 (Nesfatin) mRNA by activating the ERK1/2 pathway: isolation and characterization of the human NUCB2 gene.
    Yamada M; Horiguchi K; Umezawa R; Hashimoto K; Satoh T; Ozawa A; Shibusawa N; Monden T; Okada S; Shimizu H; Mori M
    Endocrinology; 2010 Jun; 151(6):2494-503. PubMed ID: 20427483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Troglitazone suppresses telomerase activity independently of PPARgamma in estrogen-receptor negative breast cancer cells.
    Rashid-Kolvear F; Taboski MA; Nguyen J; Wang DY; Harrington LA; Done SJ
    BMC Cancer; 2010 Jul; 10():390. PubMed ID: 20650001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peroxisome proliferator-activated receptor-gamma activity is associated with renal microvasculature.
    Guan Y; Zhang Y; Schneider A; Davis L; Breyer RM; Breyer MD
    Am J Physiol Renal Physiol; 2001 Dec; 281(6):F1036-46. PubMed ID: 11704554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A complex between 6-iodolactone and the peroxisome proliferator-activated receptor type gamma may mediate the antineoplastic effect of iodine in mammary cancer.
    Nuñez-Anita RE; Arroyo-Helguera O; Cajero-Juárez M; López-Bojorquez L; Aceves C
    Prostaglandins Other Lipid Mediat; 2009 Jun; 89(1-2):34-42. PubMed ID: 19443248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Downregulation of cyclooxygenase-2 expression and activation of caspase-3 are involved in peroxisome proliferator-activated receptor-gamma agonists induced apoptosis in human monocyte leukemia cells in vitro.
    Liu JJ; Liu PQ; Lin DJ; Xiao RZ; Huang M; Li XD; He Y; Huang RW
    Ann Hematol; 2007 Mar; 86(3):173-83. PubMed ID: 17089125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergistic interactions between heregulin and peroxisome proliferator-activated receptor-gamma (PPARgamma) agonist in breast cancer cells.
    Park BH; Lee SB; Stolz DB; Lee YJ; Lee BC
    J Biol Chem; 2011 Jun; 286(22):20087-99. PubMed ID: 21467033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of peroxisome proliferator-activated receptor gamma by troglitazone inhibits cell growth through the increase of p27KiP1 in human. Pancreatic carcinoma cells.
    Motomura W; Okumura T; Takahashi N; Obara T; Kohgo Y
    Cancer Res; 2000 Oct; 60(19):5558-64. PubMed ID: 11034103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Negative regulation of the oncogenic transcription factor FoxM1 by thiazolidinediones and mithramycin.
    Petrovic V; Costa RH; Lau LF; Raychaudhuri P; Tyner AL
    Cancer Biol Ther; 2010 Jun; 9(12):1008-16. PubMed ID: 20372080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pioglitazone, an anti-diabetic drug requires sustained MAPK activation for its anti-tumor activity in MCF7 breast cancer cells, independent of PPAR-γ pathway.
    Kole L; Sarkar M; Deb A; Giri B
    Pharmacol Rep; 2016 Feb; 68(1):144-54. PubMed ID: 26721366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of the growth arrest and DNA damage-inducible gene 45 (GADD45) by peroxisome proliferator-activated receptor gamma in vascular smooth muscle cells.
    Bruemmer D; Yin F; Liu J; Berger JP; Sakai T; Blaschke F; Fleck E; Van Herle AJ; Forman BM; Law RE
    Circ Res; 2003 Aug; 93(4):e38-47. PubMed ID: 12881480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crosstalk between peroxisome proliferator-activated receptor-γ and mineralcorticoid receptor in TNF-α activated renal tubular cell.
    Xiao J; Chen W; Lu Y; Zhang X; Fu C; Yan Z; Zhang Z; Ye Z
    Inflamm Res; 2015 Aug; 64(8):603-14. PubMed ID: 26072064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-Troglitazone-induced Apoptosis in Prostate Cancer Cells Involve AMP-activated Protein Kinase.
    Santha S; Viswakarma N; Das S; Rana A; Rana B
    J Biol Chem; 2015 Sep; 290(36):21865-75. PubMed ID: 26198640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peroxisomal proliferator-activated receptor-gamma upregulates glucokinase gene expression in beta-cells.
    Kim HI; Cha JY; Kim SY; Kim JW; Roh KJ; Seong JK; Lee NT; Choi KY; Kim KS; Ahn YH
    Diabetes; 2002 Mar; 51(3):676-85. PubMed ID: 11872666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estrogen receptor alpha binds to peroxisome proliferator-activated receptor response element and negatively interferes with peroxisome proliferator-activated receptor gamma signaling in breast cancer cells.
    Bonofiglio D; Gabriele S; Aquila S; Catalano S; Gentile M; Middea E; Giordano F; Andò S
    Clin Cancer Res; 2005 Sep; 11(17):6139-47. PubMed ID: 16144913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms regulating repression of haptoglobin production by peroxisome proliferator-activated receptor-gamma ligands in adipocytes.
    Vernochet C; Davis KE; Scherer PE; Farmer SR
    Endocrinology; 2010 Feb; 151(2):586-94. PubMed ID: 19952271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.